Option Care Health, Inc.
OPCH
Rang in Aktien
#3624
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Aktienkurs
$31.22
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$4.68B
Veränderung (1 Tag)
0.06%
Veränderung (1 Jahr)
10.01%
Land
US
Handel Option Care Health, Inc. (OPCH)
Kategorie
Healthcare
P/S-Verhältnis für Option Care Health, Inc. (OPCH)
P/S-Verhältnis zum October 2026 TTM: 0.82
Laut den neuesten Finanzberichten und dem Aktienkurs von Option Care Health, Inc. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0.82. Am Ende des Jahres 2023 lag das P/S-Verhältnis bei 1.40.
P/S-Verlauf für Option Care Health, Inc. von 2000 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 0.82 | 2.34% |
| 2024 | 0.80 | -43.18% |
| 2023 | 1.40 | 1.46% |
| 2022 | 1.38 | -7.13% |
| 2021 | 1.49 | 59.38% |
| 2020 | 0.93 | -7.52% |
| 2019 | 1.01 | 56.64% |
| 2018 | 0.64 | 46.17% |
| 2017 | 0.44 | 323.03% |
| 2016 | 0.10 | -14.87% |
| 2015 | 0.12 | -74.84% |
| 2014 | 0.49 | -14.26% |
| 2013 | 0.57 | -37.94% |
| 2012 | 0.91 | 458.40% |
| 2011 | 0.16 | 1.80% |
| 2010 | 0.16 | -34.39% |
| 2009 | 0.25 | 303.13% |
| 2008 | 0.06 | -74.98% |
| 2007 | 0.24 | 116.96% |
| 2006 | 0.11 | -53.29% |
| 2005 | 0.24 | 6.86% |
| 2004 | 0.22 | -15.19% |
| 2003 | 0.26 | 16.31% |
| 2002 | 0.23 | -72.47% |
| 2001 | 0.83 | 1,625.05% |
| 2000 | 0.05 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| 1.31 | 59.47% |
US
|
|
| - | - |
DE
|
|
| 1.00 | 22.46% |
US
|
|
| 5.31 | 548.56% |
SA
|
|
| 1.65 | 101.82% |
BR
|
